We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Janus Henderson Global Life Sciences Class H2 - Accumulation (GBP)

Sell:5,291.00p Buy:5,291.00p Change: 35.00p (0.66%)
Prices as at 17 July 2025
Sell:5,291.00p
Buy:5,291.00p
Change: 35.00p (0.66%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 17 July 2025
Sell:5,291.00p
Buy:5,291.00p
Change: 35.00p (0.66%)
Prices as at 17 July 2025
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Asset Allocation

X-ray asset allocation
Key % Net Assets
International Equities 93.40%
UK Equities 5.03%
Other 0.93%
Cash and Equiv. 0.64%

Top 10 holdings

Stock name % Weight Country Sector
1 ELI LILLY AND COMPANY 9.40% USA Pharmaceuticals & Biotechnology
2 UNITEDHEALTH GROUP INCORPORATED 6.87% USA Health Care Providers
3 ASTRAZENECA 4.00% GBR Pharmaceuticals & Biotechnology
4 JOHNSON & JOHNSON 3.59% USA Pharmaceuticals & Biotechnology
5 BOSTON SCIENTIFIC CORPORATION 3.13% USA Medical Equipment & Services
6 ABBOTT LABORATORIES 3.09% USA Medical Equipment & Services
7 SANOFI 3.06% FRA Pharmaceuticals & Biotechnology
8 AMGEN 2.89% USA Pharmaceuticals & Biotechnology
9 ABBVIE 2.83% USA Pharmaceuticals & Biotechnology
10 VERTEX PHARMACEUTICALS INC 2.82% USA Pharmaceuticals & Biotechnology

Fund Analysis is only available on the desktop version of our website. This can be accessed using a desktop or laptop PC or some larger tablets.

You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account